Yervoy 200 mg/40 mL injection Images
Generic Name: ipilimumab
This medication has been identified as Yervoy 200 mg/40 mL injection. It is supplied by Bristol-Myers Squibb Company.
Yervoy is used in the treatment of Melanoma, Metastatic; Melanoma; Colorectal Cancer; Renal Cell Carcinoma; Malignant Pleural Mesothelioma and belongs to the drug class anti-CTLA-4 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Yervoy 200 mg/40 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Yervoy
- Generic Name
- ipilimumab
- Strength
- 200 mg/40 mL injection
- Availability
- Prescription only
- Drug Class
- Anti-CTLA-4 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-2328
More about Yervoy (ipilimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.